Adjuvant Abemaciclib With Endocrine Therapy for High-Risk Early Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Adjuvant Abemaciclib Combined With Endocrine Therapy for High-Risk Early Breast Cancer: Updated Efficacy and Ki-67 Analysis From the monarchE Study
Ann. Oncol 2021 Sep 29;[EPub Ahead of Print], N Harbeck, P Rastogi, M Martin, SM Tolaney, ZM Shao, PA Fasching, CS Huang, GG Jaliffe, A Tryakin, MP Goetz, HS Rugo, E Senkus, L Testa, M Andersson, K Tamura, L Del Mastro, GG Steger, H Kreipe, R Hegg, J Sohn, V Guarneri, J Cortés, E Hamilton, V André, R Wei, S Barriga, S Sherwood, T Forrester, M Munoz, A Shahir, B San Antonio, SC Nabinger, M Toi, SRD Johnston, J O'ShaughnessyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.